Sai Parenterals Limited
Morgan Stanley's name is missing from Sai Parenterals Limited's latest shareholder list, down from a 1.17 percent stake. This shift represents either a complete exit or a reduction to just under the 1 percent reporting threshold.
A diversified pharmaceutical formulations company, Sai Parenteral's specializes in the research, development, and manufacturing of injectable and parenteral drugs for multiple therapeutic areas. Incorporated in 2001, the company maintains expertise in complex formulation technologies and operates integrated manufacturing facilities. It serves both domestic and international markets, with a focus on quality compliance and advanced pharmaceutical solutions across its product portfolio.
US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.